Meet the Start-ups

Luc Henry

Luc Henry | CEO  | Limula

Luc graduated from the University of Oxford with a DPhil in Chemical Biology. He has 10 years of research experience and published over 15 peer-reviewed scientific reports in chemistry, biotechnology and immunology. Prior to founding Limula, he was a strategic advisor to the President of EPFL, Martin Vetterli. At Limula, his role is to build meaningful partnerships to maximise the impact of our technology.



Limula

Limula is a life science platform technology company based in Lausanne, Switzerland, dedicated to transforming the manufacturing of Cell & Gene Therapies. Their mission is to accelerate the development and commercialisation of new advanced therapies through an automated, on-demand, and scalable manufacturing solution. Limula’s proprietary platform integrates all functionalities into a single device, empowering therapeutics developers to bring life-saving treatments to patients more efficiently.



Powered by:
Hyphen Projects   

    Connect     

Join Global Investor Forum

Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
         
 
 

                                    

          Register here
 
© Copyright 2023 by Hyphen Projects